NanoBio Secures $1,800,000 New Funding Round

  • Feed Type
  • Date
    2/4/2016
  • Company Name
    NanoBio
  • Mailing Address
    2311 Green Road Ann Arbor, MI 48105 USA
  • Company Description
    NanoBio Corporation is a biopharmaceutical company focused on developing and commercializing anti-infective products and mucosal vaccines derived from its patented NanoStat technology platform.
  • Website
    http://www.nanobio.com
  • Transaction Type
    Debt
  • Transaction Amount
    $1,800,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. 6 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed